Complete hematological and major molecular response through treatment
with ultra-low dose Interferon alpha 2 in polycythemia vera: a case
Early treatment of polycythemia vera with ultra-low-dose interferon-α 2a
is well tolerated and results in complete hematologic and major
molecular remission and a strong reduction of all symptoms, especially
pruritus and fatigue.